Episode 300: 299. When Do You Use a Cluster RCT?

Episode 300: 299. When Do You Use a Cluster RCT?

When you want to do an RCT but you realize there might be some cross contamination so instead of randomizing individuals you randomize cluters or groups

Lets say you want to do fluids--- what is better LR or NS instead of doing individuals and room you just put whole hospitals in either LR or NS

Or you want to test if mask work for some virus—you would say this city gets all the mask in the world and this city gets zero mask…you know that If you just gave some individuals in the city a mask then maybe someone who give their extra mask to their friends and you would have cross contamination meaning that that individuals in the group end up getting the intervention you are trying to test.

Cluster RCT are GREAT for logistics and trying to figure out logistically can something or does something actually work

However cluster RCT can be harder to analyze because the clusters may not always have the same exposures or the confounders might not be equal between clusters

In our mask example that we just talked about lets assume that one village or city never has a case of covid—will it doesn’t matter if they get mask or not because they are so isolated they never get a case of it. However if you had a perfect individual RCT the number of people in that never covid village would be exactly equal.

In the IV fluid example lets assume that one hospital gives their patients on average 20L of fluid per admission while other hospital is more reasonable in their fluid management. We know the more fluid or volume overload you are the worse your outcomes. On an individual level this wouldn’t be a problem as the same number of people would be randomized to the hospital with excess fluid exposure. So for cluster RCT while you might be able to randomize the type of fluid that cluster gets you cant control for other confounders which may throw off your result, things like exposure to the amount of fluid or type of nursing care. These excess confounders balance each other out in a individual trial as ideally individuals will have everything else the same, from volume of fluid to nursing care and the only difference will be the fluid.

Jaksot(388)

Episode 394: 402. Cardiovascular Risk Factors, Zilebesiran, Shared Decision Making

Episode 394: 402. Cardiovascular Risk Factors, Zilebesiran, Shared Decision Making

https://www.nejm.org/doi/10.1056/NEJMoa2415879?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Key Findings: Classic Risk Factors: The five risk factors examined were hype...

18 Heinä 202515min

Episode 393: 404. 3 quick articles you might want to know about (oral semaglutide, tiktok, and GLP1 thyroid cancer)

Episode 393: 404. 3 quick articles you might want to know about (oral semaglutide, tiktok, and GLP1 thyroid cancer)

GLP1 might cause thyroid cancer in mice but the evidence is drastically lacking in humansOral semaglutide is expensive for an NNT of 50 at 4 yrsTiktok videos of skin care are a scam

25 Kesä 202512min

Episode 392: 403. 3 Papers, 1 Podcast - One Guideline Changer

Episode 392: 403. 3 Papers, 1 Podcast - One Guideline Changer

https://jamanetwork.com/journals/jama/article-abstract/2834040amiloride is realistically equal to spironolactone for resistant HTNhttps://journals.lww.com/ajg/abstract/2025/05000/higher_rate_of_sponta...

16 Kesä 202514min

Episode 391: 402. Functional disability after clinically significant extracranial bleeding: a secondary analysis of ASPREE

Episode 391: 402. Functional disability after clinically significant extracranial bleeding: a secondary analysis of ASPREE

https://www.jthjournal.org/article/S1538-7836(25)00109-6/fulltextAntithrombotic agents, like aspirin and anticoagulants, are essential for treating many cardiovascular conditions. However, a common si...

5 Kesä 20257min

Episode 390: 401. Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension

Episode 390: 401. Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension

https://jamanetwork.com/journals/jama/article-abstract/2834632SummaryThe article examines the effectiveness and safety of zilebesiran, an RNA interference therapeutic agent, when used in combination w...

4 Kesä 20258min

Episode 389: 400. CRP, Lipoprotein A, LDL for cardiac risk assessment

Episode 389: 400. CRP, Lipoprotein A, LDL for cardiac risk assessment

https://www.nejm.org/doi/full/10.1056/NEJMoa2405182?query=recirc_Semantic  Key Takeaways Extended Predictive Value of Biomarkers: High-sensitivity C-reactive protein (CRP), LDL cholesterol, and lipop...

29 Touko 20259min

Episode 388: 399. Use of albumin-adjusted calcium measurements in clinical practice

Episode 388: 399. Use of albumin-adjusted calcium measurements in clinical practice

Desgagnés N et al. Use of albumin-adjusted calcium measurements in clinical practice. JAMA Netw Open 2025 Jan 21; 8:e2455251. (https://doi.org/10.1001/jamanetworkopen.2024.55251)Overall, total calcium...

27 Touko 20257min

Episode 387: 398. Which is Better, Tirzepatide or Semaglutide?

Episode 387: 398. Which is Better, Tirzepatide or Semaglutide?

https://www.nejm.org/doi/10.1056/NEJMoa2416394At 72 weeks, the mean percentage decrease in weight was significantly greater with tirzepatide than with semaglutide (20% vs. 14%). Gastrointestinal side ...

21 Touko 20258min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
tiedenaiset-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
puhu-muru
katilon-kahvitunti
rss-pitaisko-erota
meditaatiot-suomeksi
rss-pt-paahtio
audio-sport-juoksu
rss-kuumilla-aalloilla
terapiassa
selviytyjat-tarinoita-elamasta
junnut-pelissa
rss-mighty-finland-podcast
paritellen
rss-nautinto
rss-narsisti
rss-kyykkya-ja-kuoharia